Ginsenoside Rg1 improves anti-tumor efficacy of adoptive cell therapy by enhancing T cell effector functions
Yue Liu(Army Medical University), Xi Zhang(Army Medical University), Lingna An(Army Medical University), Ruihao Huang(Army Medical University), Xiaoqi Wang(Army Medical University), Chengfei Yang(Army Medical University)
Cited by 9
Related Papers
Recent advances in CAR-T cell engineering
|Journal of Hematology & Oncology|2020|403
Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma
|Cancer Cell|2020|234
TET2 Function in Hematopoietic Malignancies, Immune Regulation, and DNA Repair
|Frontiers in Oncology|2019|115
Strategies to enhance CAR-T persistence
|Biomarker Research|2022|90
Morusin exerts anti-cancer activity in renal cell carcinoma by disturbing MAPK signaling pathways
|Annals of Translational Medicine|2020|64